News
GlyTech, Inc. Enters Into Collaborative Aptamer Glycosylation Research Agreement With TAGCyx Biotechnologies
GlyTech, Inc. has signed a collaborative research agreement with TAGCyx Biotechnologies (CEO: Dr. Chizuko Koseki, Head office: Tokyo) in relation to glycosylation techniques for aptamer therapeutics.
- For more information on the collaborative research agreement with TAGCys Biotechnologies (PDF, 96KB)
Last updated: